Advertisement
Advertisement
U.S. markets close in 3 hours 18 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Clearside Biomedical, Inc. (CLSD)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
5.80+0.14 (+2.41%)
As of 12:40PM EDT. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Williams %R

Williams %R

Previous Close5.66
Open5.67
Bid5.79 x 800
Ask5.83 x 900
Day's Range5.56 - 5.87
52 Week Range1.25 - 7.73
Volume180,446
Avg. Volume526,441
Market Cap344.779M
Beta (5Y Monthly)1.78
PE Ratio (TTM)N/A
EPS (TTM)-0.44
Earnings DateNov 08, 2021 - Nov 12, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est11.60
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CLSD

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Clearside Biomedical, Inc.
    Analyst Report: Bristol-Myers Squibb Co.Bristol-Myers Squibb is a leading worldwide biopharmaceutical company. Its products focus on oncology, HIV, and cardiovascular conditions. The company completed its merger with Celgene in November 2019. BMY shares are a component of the S&P 500.
    Rating
    Fair Value
    Economic Moat
    8 months agoArgus Research
View more
Advertisement
Advertisement